Page last updated: 2024-12-11
salmfamide 1
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
SALMFamide 1: from radial nerve cords of the starfishes Asterias rubens & Asteria forbesi; also from brittle star, Amphipholis squmata [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5487416 |
MeSH ID | M0189951 |
Synonyms (15)
Synonym |
---|
salmfamide 1 |
l-phenylaninamide, glycyl-l-phenylalanyl-l-asparaginyl-l-seryl-l-alanyl-l-leucyl-l-methionyl- |
neuropeptide s1 |
glycyl-l-phenylalanyl-l-asparaginyl-l-seryl-l-alanyl-l-leucyl-l-methionyl-l-phenylaninamide |
gly-phe-asn-ser-ala-leu-met-phe-nh2 |
134439-73-9 |
gfnsalmfamide |
(2s)-2-[[(2s)-2-[(2-aminoacetyl)amino]-3-phenylpropanoyl]amino]-n-[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy |
DTXSID60158697 |
salmf-amide 1 |
(s)-n1-((5s,8s,11s,14s)-5-(((s)-1-amino-1-oxo-3-phenylpropan-2-yl)carbamoyl)-15-hydroxy-8-isobutyl-11-methyl-7,10,13-trioxo-2-thia-6,9,12-triazapentadecan-14-yl)-2-((s)-2-(2-aminoacetamido)-3-phenylpropanamido)succinamide |
HY-P2042 |
salmf amide 1 |
CS-0107544 |
AKOS040753906 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (21)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (42.86) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 5 (23.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (4.55%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 21 (95.45%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |